Pfizer Recalls Sodium Bicarbonate Injection Vials Due to Glass Particulates
Pfizer is recalling 8.4% Sodium Bicarbonate Injection vials because they contain glass particulates. The recall covers 283,400 vials distributed in the United States and Puerto Rico.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The source metadata explicitly identifies the agency classification as Class I. According to the severity rubric, an FDA Class I recall corresponds to a score of 5 (Critical).
Plain-English summary
Pfizer Inc. is recalling 8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vials. The recall is due to the presence of particulate matter, specifically glass particulates, in the product. The affected product is identified by NDC 0409-6625-02 and was manufactured by Hospira, Inc. in Lake Forest, IL.
The recall involves 283,400 vials. The specific lots affected are 79-238-EV (Exp. 1 July 2019), 79-240-EV (Exp. 1 July 2019), and 80-088-EV (Exp. 1 August 2019). These products were distributed in the United States and Puerto Rico.
Healthcare providers and patients should stop using the affected vials and contact Pfizer or their supplier for instructions on how to return the product. This recall is classified as Class I by the FDA, indicating a reasonable probability that use of the product may cause serious adverse health consequences or death.
The recalled product
- Product
- 8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial, 25 vials per carton, Rx only Hospira, Inc. Lake Forest, IL 60045 USA ---- NDC 0409-6625-02
- Manufacturer
- Pfizer Inc.
- Category
- Drug — Injectable
- Affected units
- 283,400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots: 79-238-EV Exp. 1 July 2019
- 79-240-EV Exp. 1 July 2019
- 80-088-EV Exp. 1 August 2019
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Pfizer Inc.
See all →- HighSodium bicarbonate injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighEpinephrine injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighBicillin L-A 2.4 million unit vials recalled after particulates found
FDA (Drugs) · 2025-08-06
- HighBicillin L-A penicillin vials recalled after particulates found during visual inspection
FDA (Drugs) · 2025-08-06
- ModerateDobutamine Injection Recall Due to Discoloration and Cracked Vials
FDA (Drugs) · 2025-07-02
Same hazard · glass particulates
See all →- HighEquate Cherry Cough Drops recalled for potential glass and silicone contamination
FDA (Drugs) · 2024-02-28
- SevereQuVa Pharma Recalls Fentanyl and Ropivacaine Bags Due to Glass Particulates
FDA (Drugs) · 2019-12-11
- SevereQuVa Pharma Recalls Fentanyl Injection Bags Due to Glass Particulates
FDA (Drugs) · 2019-12-11
- SevereQuVa Pharma Recalls Fentanyl and Bupivacaine Infusion Due to Glass Particulates
FDA (Drugs) · 2019-12-11
- SevereFresenius Kabi Recalls Fosphenytoin Sodium Injection Due to Glass Particulates
FDA (Drugs) · 2014-07-16